港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

医美概念股

687.509

-29.731-4.15%

涨家数：3

跌家数：7

平家数：3

市盈率：- -

高：696.344

开：678.885

低：675.692

收：717.241

数据加载中...

总览新闻资讯

四环医药(00460)出现大手买入280万股，成交价$0.66，涉资184.8万

阿斯达克财经

瑞丽医美盘中异动下午盘股价大涨7.08%

瑞丽医美(02135)股价上升7.08%，现价港币$0.121

阿斯达克财经

复星医药(02196.HK)附属组合伙投资医疗器械诊断

阿斯达克财经

三生制药盘中异动早盘急速跳水9.37%报11.800港元

康哲药业分拆德镁医药上市，后者连续三年亏损

复星医药(02196)完成发行2025年度第一期中期票据(科创票据)

【四环医药(00460.HK)：渼颜空间自主研发的聚乳酸面部填充剂(童颜针)获得国家药监局上市批准】四环医药(00460.HK)发布公告，集团旗下渼颜空间生物科技(吉林)有限公司自主研发的聚乳酸面部填充剂(该产品)正式获得中国国家药品监督管理局批准的第三类医疗器械注册证，用以纠正中重度鼻唇沟皱纹。标志着四环医药在再生医美领域的又一重大突破，进一步巩固了集团在高端医美材料市场的技术领先地位。

四环医药：渼颜空间自主研发的童颜针获得国家药监局上市批准

三生制药：非执董张皎娥减持 6000 股

三生制药遭非执行董事张皎娥减持6000股每股作价12.88港元

昊海生物科技公布第一季度业绩归母净利约9031.21万元同比减少7.41%

昊海生物科技(06826)公布第一季度业绩归母净利约9031.21万元同比减少7.41%

复星医药拟设立河南复健加强大健康产业布局

复星医药控股子公司复星平耀拟出资 490 万元参设河南复健

市值两百亿药企分拆！“皮肤”业务将上市……

国际金融报

非执行董事张皎娥减持三生制药(01530)6000股每股作价12.88港元

智通财经网

现代牙科(03600)4月25日耗资约42.76万港元回购10万股

三生制药04月25日主力净流出1393万元散户资金买入

复星医药04月25日获主力加仓75万元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1593/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"医美概念股","latestPrice":687.50946,"timestamp":1745824882170,"preClose":717.24054,"halted":0,"volume":147197558,"delay":0,"changeRate":-0.041452,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-29.731079,"latestTime":"04-28 15:21:23","open":678.8851,"high":696.34436,"low":675.6922,"amount":1221546745,"amplitude":0.028794,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1745827800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1745803800000,1745812800000],[1745816400000,1745827200000]],"pbRate":1.255448,"peRate":19.315719,"turnoverRate":0.007361,"increases":3,"decrements":7,"flats":3,"marketCap":118387136232,"floatMarketCap":82404568168},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":696.34436,"amplitude":0.028794,"preClose":717.24054,"low":675.6922,"pbRate":"1.255448","latestPrice":687.50946,"volume":147197558,"delay":0,"open":678.8851,"prevYearClose":571.87146,"prevWeekClose":717.241,"prevMonthClose":677.607,"prevQuarterClose":677.607,"fiveDayClose":661.02,"twentyDayClose":662.617,"sixtyDayClose":538.937,"secType":"PLATE","market":"HK","turnoverRate":0.007361,"peRate":19.315719,"marketCap":118387136232,"floatMarketCap":82404568168,"timestamp":1745824882170,"nameCN":"医美概念股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":3,"down":7,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2530448594","title":"四环医药(00460)出现大手买入280万股，成交价$0.66，涉资184.8万","url":"https://stock-news.laohu8.com/highlight/detail?id=2530448594","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530448594?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 14:00","pubTimestamp":1745820000,"startTime":"0","endTime":"0","summary":"[大手成交]四环医药(00460)在下午02:00出现大手买入，成交量为280万，成交价为港币$0.66，涉资184.8万。至目前为止，股价跌1.515%，今日最高价为$0.69，而最低价为$0.65，总成交量为2.302千万股，总成交金额港币$1.535千万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145549237_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145549237_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2504287920/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1600","00460","BK1515","BK1191","BK1593"],"gpt_icon":0},{"id":"2530844383","title":"瑞丽医美盘中异动 下午盘股价大涨7.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530844383","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530844383?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 13:58","pubTimestamp":1745819928,"startTime":"0","endTime":"0","summary":"2025年04月28日下午盘13时58分，瑞丽医美股票出现异动，股价快速上涨7.08%。截至发稿，该股报0.121港元/股，成交量1.4万股，换手率0.00%，振幅0.00%。瑞丽医美股票所在的医疗及医学美容服务行业中，整体跌幅为0.34%。其相关个股中，万嘉集团、奥思集团、亮晴控股涨幅较大，振幅较大的相关个股有亮晴控股、中国再生医学、熙康云医院，振幅分别为19.49%、9.52%、6.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428135848a6cb32df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428135848a6cb32df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02135","BK1593","BK1209"],"gpt_icon":0},{"id":"2530448307","title":"瑞丽医美(02135)股价上升7.08%，现价港币$0.121","url":"https://stock-news.laohu8.com/highlight/detail?id=2530448307","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530448307?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 13:58","pubTimestamp":1745819880,"startTime":"0","endTime":"0","summary":"[上升股]瑞丽医美(02135) 股价在下午01:58比前收市价上升7.08%，现股价为港币$0.121。至目前为止，今日最高价为$0.121，而最低价为$0.121。总成交量为1.4万股，总成交金额为港币$1610。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR250428909/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02135","BK1593","BK1209"],"gpt_icon":0},{"id":"2530349452","title":"复星医药(02196.HK)附属组合伙投资医疗器械诊断","url":"https://stock-news.laohu8.com/highlight/detail?id=2530349452","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530349452?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 09:54","pubTimestamp":1745805240,"startTime":"0","endTime":"0","summary":"复星医药(02196.HK) 公布，附属复星平耀与上海复健、控股股东复星高科技及复曜智港签订合伙协议，拟共同设立河南复健，分别以现金出资490万、10万、290万、210万元人民币，权益占比分别为49%、1%、29%、21%。复星医药指，为加强大健康产业的布局，拟参与发起设立以中原地区为中心，以医疗器械诊断、生命科学、创新药及其上下游产业链为主要投资方向的股权投资基金。河南复健设立后，拟作为发起设立该股权投资基金的普通合伙人。(ha/a)(港股报价延迟最少十五分钟。沽空资料截至 2025-04-25 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220221174704291_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220221174704291_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1436237/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09997","09996","BK0239","BK0183","159883","BK1191","BK0187","BK1593","BK0096","BK1222","BK0028","BK0196","BK0188","BK1515","02196","BK1583","600196","BK0060","BK0012","BK1574","BK0175","BK1100"],"gpt_icon":0},{"id":"2530999704","title":"三生制药盘中异动 早盘急速跳水9.37%报11.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530999704","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530999704?lang=zh_cn&edition=fundamental","pubTime":"2025-04-28 09:39","pubTimestamp":1745804375,"startTime":"0","endTime":"0","summary":"2025年04月28日早盘09时39分，三生制药股票出现波动，股价快速跳水9.37%。截至发稿，该股报11.800港元/股，成交量2153.9万股，换手率0.90%，振幅7.07%。三生制药股票所在的药品行业中，整体跌幅为0.43%。其相关个股中，四环医药、海王英特龙、金嗓子涨幅较大，振幅较大的相关个股有三生制药、东阳光长江药业、翰森制药，振幅分别为7.07%、6.56%、6.07%。减持后其最新持股数目约为 1248.66 万股，最新持股比例为 0.52%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428093935a469c1d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428093935a469c1d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1593","01530","BK1161"],"gpt_icon":0},{"id":"2530453738","title":"康哲药业分拆德镁医药上市，后者连续三年亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=2530453738","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530453738?lang=zh_cn&edition=fundamental","pubTime":"2025-04-27 21:38","pubTimestamp":1745761125,"startTime":"0","endTime":"0","summary":"港股上市公司康哲药业近日发布公告，将附属公司德镁医药股份分拆并于联交所主板独立上市。德镁医药主要负责康哲药业在国内的皮肤健康业务，最近三年均处亏损状态。目前，德镁医药已向联交所递交申请，康哲药业表示，分拆预计将通过由康哲药业以实物方式向股东分派其持有的所有德镁医药股份的方式实施。德镁医药为康哲药业附属公司，德镁医药90.8%权益由康哲药业实益拥有。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504273390338112.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504273390338112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00BYV24P56.USD","BK1574","SG9999015945.SGD","09939","00867","IE00BMCWC346.EUR","SG9999015978.USD","BK1515","SG9999004220.SGD","LU2488822045.USD","SG9999015952.SGD","BK1161","BK1191","SG9999015986.USD","BK1593"],"gpt_icon":0},{"id":"2530431472","title":"复星医药(02196)完成发行2025年度第一期中期票据(科创票据)","url":"https://stock-news.laohu8.com/highlight/detail?id=2530431472","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530431472?lang=zh_cn&edition=fundamental","pubTime":"2025-04-27 18:58","pubTimestamp":1745751538,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(02196)发布公告，公司近日于通知书项下注册额度内完成2025年度第一期中期票据(科创票据)(本期中期票据)的发行。中期票据简称：25复星医药MTN001(科创票据)，实际发行总额人民币5亿元，期限2年。发行利率3.10%，起息日期2025年4月25日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1285953.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK0239","159982","BK0028","BK0175","BK0096","600196","BK0183","BK0187","BK0188","BK0196","02196","BK1191","BK0060","BK1593","BK0012"],"gpt_icon":0},{"id":"2530243190","title":"【四环医药(00460.HK)：渼颜空间自主研发的聚乳酸面部填充剂(童颜针)获得国家药监局上市批准】四环医药(00460.HK)发布公告，集团旗下渼颜空间生物科技(吉林)有限公司自主研发的聚乳酸面部填充剂(该产品)正式获得中国国家药品监督管理局批准的第三类医疗器械注册证，用以纠正中重度鼻唇沟皱纹。标志着四环医药在再生医美领域的又一重大突破，进一步巩固了集团在高端医美材料市场的技术领先地位。","url":"https://stock-news.laohu8.com/highlight/detail?id=2530243190","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530243190?lang=zh_cn&edition=fundamental","pubTime":"2025-04-27 18:57","pubTimestamp":1745751459,"startTime":"0","endTime":"0","summary":"四环医药(00460.HK)发布公告，集团旗下渼颜空间生物科技(吉林)有限公司自主研发的聚乳酸面部填充剂(该产品)正式获得中国国家药品监督管理局批准的第三类医疗器械注册证，用以纠正中重度鼻唇沟皱纹。标志着四环医药在再生医美领域的又一重大突破，进一步巩固了集团在高端医美材料市场的技术领先地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/27185749930234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1583","BK1191","BK1593","159883","09996","BK1222","09997","000973.SH","BK1515","BK1574","159837","BK1600","00460","BK1100"],"gpt_icon":0},{"id":"2530395634","title":"四环医药：渼颜空间自主研发的童颜针获得国家药监局上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2530395634","media":"格隆汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530395634?lang=zh_cn&edition=fundamental","pubTime":"2025-04-27 18:26","pubTimestamp":1745749560,"startTime":"0","endTime":"0","summary":"格隆汇4月27日丨四环医药宣布，集团旗下渼颜空间生物科技(吉林)有限公司自主研发的聚乳酸面部填充剂正式获得中国国家药品监督管理局批准的第三类医疗器械注册证，用以纠正中重度鼻唇沟皱纹。渼颜空间自主研发的“童颜针”，采用独特的专利技术，使其含有的左旋聚乳酸微球具有形态更规则、粒径分布更均一、品质稳定性更高的特点，显着提高产品的安全性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427182830a4691469&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427182830a4691469&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1515","BK1600","00460","BK1191"],"gpt_icon":0},{"id":"2530101474","title":"三生制药：非执董张皎娥减持 6000 股","url":"https://stock-news.laohu8.com/highlight/detail?id=2530101474","media":"和讯网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530101474?lang=zh_cn&edition=fundamental","pubTime":"2025-04-27 08:42","pubTimestamp":1745714565,"startTime":"0","endTime":"0","summary":"【香港联交所：4 月 24 日三生制药非执行董事张皎娥减持 6000 股】4 月 24 日，香港联交所最新资料显示，三生制药非执行董事张皎娥减持 6000 股。每股作价 12.88 港元，总金额约为 7.73 万港元。减持后其最新持股数目约为 1248.66 万股，最新持股比例为 0.52%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504271014099746e14a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504271014099746e14a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01530","BK1593","BK1161","BK1583"],"gpt_icon":0},{"id":"2530868105","title":"三生制药遭非执行董事张皎娥减持6000股 每股作价12.88港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530868105","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530868105?lang=zh_cn&edition=fundamental","pubTime":"2025-04-27 08:32","pubTimestamp":1745713920,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　香港联交所最新资料显示，4月24日，非执行董事张皎娥减持三生制药（01530）6000股，每股作价12.88港元，总金额约为7.73万港元。减持后最新持股数目约为1248.66万股，最新持股比例为0.52%。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-04-27/doc-ineuqcqi7922093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","01530","BK1583","BK1593"],"gpt_icon":0},{"id":"2530571531","title":"昊海生物科技公布第一季度业绩 归母净利约9031.21万元 同比减少7.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530571531","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530571531?lang=zh_cn&edition=fundamental","pubTime":"2025-04-26 00:32","pubTimestamp":1745598720,"startTime":"0","endTime":"0","summary":"昊海生物科技(06826)公布2025年第一季度业绩，营业收入约6.185亿元，同...昊海生物科技(06826)公布2025年第一季度业绩，营业收入约6.185亿元，同比减少4.25%;归属于上市公司股东的净利润约9031.21万元，同比减少7.41%;基本每股收益0.39元。追加内容本文作者可以追加内容哦 !","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426003333a6c846da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426003333a6c846da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06826","BK1593","BK1161"],"gpt_icon":0},{"id":"2530282131","title":"昊海生物科技(06826)公布第一季度业绩 归母净利约9031.21万元 同比减少7.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530282131","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530282131?lang=zh_cn&edition=fundamental","pubTime":"2025-04-25 21:49","pubTimestamp":1745588992,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)公布2025年第一季度业绩，营业收入约6.185亿元，同比减少4.25%;归属于上市公司股东的净利润约9031.21万元，同比减少7.41%;基本每股收益0.39元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1285463.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1593","06826"],"gpt_icon":0},{"id":"2530136358","title":"复星医药拟设立河南复健 加强大健康产业布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2530136358","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530136358?lang=zh_cn&edition=fundamental","pubTime":"2025-04-25 20:56","pubTimestamp":1745585792,"startTime":"0","endTime":"0","summary":"格隆汇4月25日丨复星医药公告，于2025年4月25日，公司附属公司复星平耀与上海复健、复星高科技及复曜智港签订合伙协议，据此，各方拟共同设立河南复健。为加强大健康产业的布局，集团拟参与发起设立以中原地区为中心，以医疗器械诊断、生命科学、创新药及其上下游产业链为主要投资方向的股权投资基金。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042520563297450d53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042520563297450d53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","BK1191","BK1593","BK1515"],"gpt_icon":0},{"id":"2530518756","title":"复星医药控股子公司复星平耀拟出资 490 万元参设河南复健","url":"https://stock-news.laohu8.com/highlight/detail?id=2530518756","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530518756?lang=zh_cn&edition=fundamental","pubTime":"2025-04-25 20:14","pubTimestamp":1745583294,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药 公布，2025 年 4 月 25 日，公司控股子公司复星平耀与上海复健、复星高科技、复曜智港拟分别出资人民币 490 万元、10 万元、290 万元和 210 万元共同设立河南复健。河南复健设立后，复星平耀、上海复健、复星高科技、复曜智港将分别持有其 49%、1%、29%和 21%的财产份额。为加强大健康产业的布局，该集团拟参与发起设立以中原地区为中心，以医疗器械诊断、生命科学、创新药及其上下游产业链为主要投资方向的股权投资基金。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425202007974502f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425202007974502f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1515","02196","BK1191"],"gpt_icon":0},{"id":"2530188793","title":"市值两百亿药企分拆！“皮肤”业务将上市……","url":"https://stock-news.laohu8.com/highlight/detail?id=2530188793","media":"国际金融报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530188793?lang=zh_cn&edition=fundamental","pubTime":"2025-04-25 18:28","pubTimestamp":1745576920,"startTime":"0","endTime":"0","summary":"近日，康哲药业(00867.HK)发布公告，建议将旗下皮肤业务附属公司德镁医药股份分拆并在港交所主板独立上市。同时，德镁医药有限公司（下称“德镁医药”）向港交所提交了上市申请，独家保荐人为华泰国际。需要指出的是，康哲药业此次分拆将以实物方式向其股东分派其持有的所有德镁医药股份，而德镁医药以介绍方式在香港主板上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202504253388975578.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504253388975578.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SG9999015952.SGD","BK1574","SG9999015986.USD","BK4096","BK1161","BK1191","IE00BYV24P56.USD","SG9999004220.SGD","SG9999015945.SGD","BK1593","BK1515","09939","IE00BMCWC346.EUR","PN","00867","SG9999015978.USD","LU2488822045.USD"],"gpt_icon":0},{"id":"2530189986","title":"非执行董事张皎娥减持三生制药(01530)6000股 每股作价12.88港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530189986","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530189986?lang=zh_cn&edition=fundamental","pubTime":"2025-04-25 18:25","pubTimestamp":1745576700,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，4月24日，非执行董事张皎娥减持三生制药(01530)6000股，每股作价12.88港元，总金额约为7.73万港元。减持后最新持股数目约为1248.66万股，最新持股比例为0.52%。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-04-25/doc-ineuksvt1916383.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01530","BK1593","BK1583","BK1161"],"gpt_icon":0},{"id":"2530977714","title":"现代牙科(03600)4月25日耗资约42.76万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2530977714","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530977714?lang=zh_cn&edition=fundamental","pubTime":"2025-04-25 16:42","pubTimestamp":1745570531,"startTime":"0","endTime":"0","summary":"智通财经APP讯，现代牙科(03600)公布，2025年4月25日耗资约42.76万港元回购10万股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1284943.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1593","03600","BK1100"],"gpt_icon":0},{"id":"2530035719","title":"三生制药04月25日主力净流出1393万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2530035719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530035719?lang=zh_cn&edition=fundamental","pubTime":"2025-04-25 16:16","pubTimestamp":1745569015,"startTime":"0","endTime":"0","summary":"04月25日, 三生制药股价跌2.69%，报收13.02元，成交金额5.70亿元，换手率1.80%，振幅8.37%，量比1.01。三生制药今日主力资金净流出1393万元，上一交易日主力净流入4482万元。该股近5个交易日上涨7.79%，主力资金累计净流入1824万元；近20日主力资金累计净流入2.65亿元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425170837a6c7cf44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425170837a6c7cf44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","01530","BK1161","BK1593"],"gpt_icon":0},{"id":"2530905488","title":"复星医药04月25日获主力加仓75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530905488","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530905488?lang=zh_cn&edition=fundamental","pubTime":"2025-04-25 16:15","pubTimestamp":1745568956,"startTime":"0","endTime":"0","summary":"04月25日, 复星医药股价涨0.27%，报收14.84元，成交金额5167万元，换手率0.64%，振幅2.70%，量比0.87。复星医药今日主力资金净流入75万元，上一交易日主力净流入177万元。该股近5个交易日上涨7.53%，主力资金累计净流出188万元；近20日主力资金累计净流入1372万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425170256a6c7cdb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425170256a6c7cdb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","02196","BK1593"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":110,"code":"91000000","status":"200"}]}}